AAF
ALXN

Andra AP-fonden’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-119,700
Closed -$22M 617
2021
Q2
$22M Sell
119,700
-5,500
-4% -$1.01M 0.45% 2
2021
Q1
$19.1M Buy
125,200
+7,200
+6% +$1.1M 0.42% 5
2020
Q4
$18.4M Buy
118,000
+48,800
+71% +$7.62M 0.41% 5
2020
Q3
$7.92M Buy
69,200
+9,200
+15% +$1.05M 0.21% 142
2020
Q2
$6.73M Buy
60,000
+10,400
+21% +$1.17M 0.2% 166
2020
Q1
$4.45M Buy
49,600
+3,900
+9% +$350K 0.16% 280
2019
Q4
$4.94M Buy
45,700
+17,800
+64% +$1.92M 0.14% 385
2019
Q3
$2.73M Buy
27,900
+5,400
+24% +$529K 0.08% 563
2019
Q2
$2.95M Buy
22,500
+4,600
+26% +$602K 0.08% 567
2019
Q1
$2.42M Buy
+17,900
New +$2.42M 0.07% 579
2018
Q3
$2.36M Buy
17,000
+5,000
+42% +$695K 0.06% 582
2018
Q2
$1.49M Sell
12,000
-11,500
-49% -$1.43M 0.04% 612
2018
Q1
$2.62M Buy
23,500
+9,300
+65% +$1.04M 0.07% 591
2017
Q4
$1.7M Buy
14,200
+5,200
+58% +$622K 0.04% 594
2017
Q3
$1.26M Buy
9,000
+1,000
+13% +$140K 0.03% 618
2017
Q2
$973K Buy
+8,000
New +$973K 0.02% 635
2017
Q1
Sell
-2,000
Closed -$245K 656
2016
Q4
$245K Buy
+2,000
New +$245K 0.01% 643
2016
Q3
Sell
-7,100
Closed -$829K 646
2016
Q2
$829K Buy
7,100
+1,200
+20% +$140K 0.02% 632
2016
Q1
$821K Sell
5,900
-700
-11% -$97.4K 0.02% 629
2015
Q4
$1.26M Sell
6,600
-4,800
-42% -$916K 0.04% 543
2015
Q3
$1.78M Sell
11,400
-1,000
-8% -$156K 0.05% 492
2015
Q2
$2.24M Sell
12,400
-1,100
-8% -$199K 0.06% 437
2015
Q1
$2.34M Sell
13,500
-4,000
-23% -$693K 0.07% 417
2014
Q4
$3.24M Sell
17,500
-10,500
-38% -$1.94M 0.08% 373
2014
Q3
$4.64M Sell
28,000
-7,600
-21% -$1.26M 0.11% 288
2014
Q2
$5.56M Sell
35,600
-13,600
-28% -$2.12M 0.12% 250
2014
Q1
$7.49M Buy
49,200
+16,900
+52% +$2.57M 0.17% 190
2013
Q4
$4.3M Buy
32,300
+19,000
+143% +$2.53M 0.1% 313
2013
Q3
$1.55M Buy
13,300
+6,500
+96% +$755K 0.04% 456
2013
Q2
$627K Buy
+6,800
New +$627K 0.02% 522